A subscription to JoVE is required to view this content. Sign in or start your free trial.
* These authors contributed equally
The present protocol describes an efficient method for screening drugs that enhance myocardial contractility using isolated right atria from guinea pigs.
Common chronic heart failure (CHF) is characterized by impaired ventricular filling and/or ejection function, which leads to insatiable cardiac output and increased incidence. The decline in cardiac systolic function is a key factor in the pathogenesis of CHF. Systolic function is simply the filling of oxygenated blood in the left ventricle, followed by the blood being pumped throughout the body during a heartbeat. A weak heart and the inability of the left ventricle to contract appropriately as the heart beats indicate poor systolic function. Many traditional herbs have been suggested to strengthen the systolic function of the heart in patients. However, stable and efficient experimental methods for screening compounds that enhance myocardial contractility are still lacking in the process of ethnic medicine research. Here, taking digoxin as an example, a systematic and standardized protocol is provided for screening compounds that enhance myocardial contractility by using isolated right atria from guinea pigs. The results showed that digoxin could markedly enhance the contractility of the right atrium. This systematic and standardized protocol is intended to serve as a methodological reference for screening the active ingredients of ethnic medicines in the treatment of CHF.
Heart failure is caused by myocardial infarction, myocardiopathy, hemodynamic overload, inflammation, and other causes of myocardial injuries, which modify the myocardial anatomy and activity and, ultimately, lead to failure in the ventricular pumping or filling. Palpitations, tiredness, and fluid retention are the main primary clinical symptoms1. CHF is a chronic heart failure condition that can be maintained, deteriorate, or show decompensation over time, and its incidence and prevalence increase with age2. The decline in cardiac systolic function is a key factor in the pathogenesis of CHF3. The....
The experimental protocol was conducted in accordance with the requirements of the Use of Laboratory Animals and Institutional Animal Care and Use Committee at Ningxia Medical University. Male Dunkin-Hartley guinea pigs weighing 300-450 g were used for the present study. The effect of digoxin on contractility was observed in isolated right atria from the guinea pigs (Figure 2).
1. Oxygenation preparation for the isolated right atria of guinea pigs
A decrease in myocardial contractility causes insufficient cardiac output, which leads to CHF (Figure 1). This protocol allowed the recording of the effects of different drugs on the systolic function of isolated right atria from guinea pigs and then the rapid screening of compounds from ethnic drugs that enhance myocardial contractility. After connecting the right atrium, the JH-2 muscle force transducer, and the biological signal acquisition and processing system in steps, the parameters w.......
The normal rhythmic activity of the heart requires a suitable physical and chemical environment, as does the activity of isolated right atria. Isolated right atria are isolated from the innervation of the body and the direct influence of systemic humoral factors, meaning changes in the activity of the right atria when changing the drugs they are exposed to can be observed. The fundamental causes of bioelectrical activity in excitable cells are changes in the ion permeability of the cell membrane and the subsequent diffus.......
This work was supported by the Ningxia Natural Science Foundation (Grant no. 2023AAC03620), the Scientific Research Project of the Higher Education Department of Ningxia (NYG2022030), and the National Natural Science Foundations of China (Grant no.82160816 and 82260797).
....Name | Company | Catalog Number | Comments |
4-0 surgical suture | Yangzhou Fuda Medical Devices Co., Ltd | ||
5% Digoxin (soluble in dimethyl sulfoxide) | TCI Shanghai | D1828 | CAS: 20830-75-5; Purity: >96.0% |
BL-420N biological signal acquisition and processing system | Chengdu Tai Meng Software Co., Ltd | 1700142S | |
CaCl2 | Shanghai yuanye Bio-Technology Co., Ltd | S24110 | CAS: 10043-52-4; Purity: 96% |
Glucose | Shanghai yuanye Bio-Technology Co., Ltd | S11022 | CAS: 50-99-7; Purity: 99% |
Isoflurane | RWD Life Science Co., Ltd | R510-22-16 | |
JH-2 muscle force transducer | Institute of Aerospace Medical Engineering, Beijing, China | ||
KCl | Shanghai yuanye Bio-Technology Co., Ltd | S24120 | CAS: 7447-40-7; Purity: 99.5% |
Magnus bath | Shanghai Future Experimental Equipment Co., Ltd | L046525 | |
MgSO4 | Shanghai yuanye Bio-Technology Co., Ltd | S24253 | CAS: 7487-88-9; Purity: 98% |
NaCl | Shanghai yuanye Bio-Technology Co., Ltd | S24119 | CAS: 7647-14-5; Purity: 99.5% |
NaH2PO4 | Shanghai yuanye Bio-Technology Co., Ltd | S24161 | CAS: 7558-80-7; Purity: 99% |
NaHCO3 | Shanghai yuanye Bio-Technology Co., Ltd | S24153 | CAS: 144-55-8; Purity: 99.8% |
Operating basin | Guangzhou Telekuan Medical Instrument Co., Ltd | 305 mm x 230 mm | |
Ophthalmic forcep | Suzhou Shuanglu Medical Instrument Co., Ltd | ||
Ophthalmic operating scissor |  Suzhou Shuanglu Medical Instrument Co., Ltd | ||
Paraffin | Leica Biosystems | 39601095 | |
Petri dish | Corning | 430167 | 100 mm x 20 mm |
Rodent anesthesia machine | Shanghai Yuyan Instruments Co., Ltd | ABS type (single channel) | |
Scale | Shanghai Yueping Scientific Instrument Co., Ltd | YP1002 | |
Surgical plate |  Zhengzhou Ketai Experiment Equipment Co., Ltd | 21 cm x 31 cm | |
Tissue scissor | Suzhou Shuanglu Medical Instrument Co., Ltd | SL0023 |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved